Le Lézard
Classified in: Health, Science and technology
Subject: NEW PRODUCTS/SERVICES

TeraRecon Unveils iNtuition AI Data Extractor


DURHAM, N.C., June 27, 2019 (GLOBE NEWSWIRE) -- Artificial Intelligence (AI) and advanced visualization innovator, TeraRecon, today announced its new iNtuition AI Data ExtractorTM, a technology breakthrough that empowers its clients to automatically transform clinicians' archived and day-forward advanced visualization data into valuable AI research-ready training data-sets.

With the addition of the iNtuition AI Data Extractor, users can quickly convert iNtuitionTM post-processed data - completed in the normal course of routine clinical reading workflow into volumetric, high-fidelity labeled data sets. This data can be further optimized by leveraging iNtuition as a powerful, clinical-quality data labeler and used by data scientists to create and train algorithms. The Extractor will be offered to customers free for the first 90 studies, with a low per-image extraction fee thereafter. TeraRecon customers can now derive new value from many years of past physician, technologist and system-based advanced 3D post-processing by leveraging the iNtuition AI Data Extractor and converting exported files into the necessary formats for continuous algorithm development and training.

TeraRecon is used within many of the highest volume 3D post-processing labs, some of which process approximately 200,000 studies per year. "At 3DR, we have 100 full-time 3D technologists who are highly skilled at segmentation and anatomic labeling. They have a deep understanding of our clients' diagnostic interpretation requirements and produce 3D post-processed imaging data sets used by many of the most prestigious health systems in America." said Dr. Robert Falk, Chief Medical Officer at 3DR Laboratories in Louisville, Kentucky. "Our most sophisticated work is performed on TeraRecon's iNtuition solution. We are proud to be able to offer this profoundly simple way for our customers to access the AI Extractor technology and immediately unlock the value of their data."

Shannon Walters, Executive Manager of a prominent 3D and quantitative imaging lab said, "The most important thing that AI can do for my department is help people do their work better day-by-day. I am excited that the clinical expertise of my staff can now be utilized in the development of new AI tools." 

The iNtuition AI Data Extractor is made available as an engine that runs locally or in the cloud as part of the EnvoyAITM platform. This new offering is the first in a series of developer-focused EnvoyAI engines that will streamline the training, delivery and application of new AI algorithms.

EnvoyAI is the world's first medical imaging AI marketplace and interoperability platform, currently offering over 80 algorithms with 20 holding regulatory clearances in various global territories. All EnvoyAI marketplace algorithms, including the iNtuition AI Data Extractor, are offered with a free trial period allowing clinicians to experiment with the ever-growing number of commercial-ready and research-use AI products.

TeraRecon technologies including the EnvoyAI platform, TeraRecon Northstar AI Results ExplorerTM, and its flagship iNtuition advanced visualization solution, are on display at the Society for Imaging Informatics in Medicine (Book a demo at SIIM) in Aurora, Colorado from June 26th ? June 28th, 2019. Online demonstrations are available by contacting TeraRecon at [email protected].

About TeraRecon (www.terarecon.com) TeraRecon is a leader in medical advanced visualization and artificial intelligence solutions. Their flagship product, iNtuition, consistently leads the advanced visualization category of the industry's leading independent technology analyst. The company continues to innovate ahead of customer demand and has most recently developed new sophisticated healthcare-focused artificial intelligence platform solutions unlike any in the world today. EnvoyAI was the recipient of the prestigious Aunt Minnie 2018 Best New Radiology Vendor award. TeraRecon's Northstar AI Results Explorer is the first and only enterprise-wide solution capable of delivering AI imaging insights directly and interactively into the systems clinicians use every day. As a company with a 20-year history of innovation, TeraRecon's mission is to continuously redefine medical advanced visualization and leverage artificial intelligence to improve patient care.

Press Inquiries US: 1-650-372-1100 | [email protected]

TeraRecon, iNtuition, EnvoyAI, Northstar and the iNtuition AI Data Extractor are trademarks of TeraRecon, Inc.


These press releases may also interest you

at 05:34
Sungrow, a global leading PV inverter and energy storage system supplier, has emerged as one of the standout companies on the 2024 Fortune Asia Future 30 list. The list, which recognizes the most promising companies in Asia Pacific, is a testament to...

at 05:30
Cato Networks, the SASE leader, announced a new SASE throughput record here at the Porsche Studio Ginza ahead of the 2024 Tokyo E-Prix, achieving 10 Gbps without hardware upgrades. At 10 Gbps, Cato became the first SASE platform to compete not only...

at 05:20
Roborock, a global leader in ultra-intelligent home robotics engineered to simplify daily life, today announced it has taken the number one spot for robotic vacuum sales worldwide, according to new data by Euromonitor. Celebrating its achievements at...

at 05:20
IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, today announced that China National Medical Products Administration (NMPA) has approved the...

at 05:15
The "Flow Cytometry Markets. Forecasts by Technology, Product and Application. With Executive and Consultant Guides. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. The technology is moving faster than the market. Find the...

at 05:00
TAL Education Group ("TAL" or the "Company") , a smart learning solutions provider in China, today announced that it will release its unaudited financial results for the fourth quarter and fiscal year 2024 ended February 29, 2024, before the market...



News published on and distributed by: